Texas Capital Bank Wealth Management Services’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$337K Buy
+2,205
New +$338K 0.02% 255
2020
Q4
Sell
-25,860
Closed -$2.25M 157
2020
Q3
$2.25M Buy
+25,860
New +$2.24M 0.37% 54

Other funds holding NVS

Texas Capital Bank Wealth Management Services's NVS Position: Q1 2026 in Review

Texas Capital Bank Wealth Management Services opened a new position in Novartis (NVS) in Q1 2026: 2,205 shares worth $337K. The stake represents 0.02% of the portfolio and ranks #255 among its holdings. This is a return to the name: Texas Capital Bank Wealth Management Services previously reported a position in NVS as recently as Q3 2020.

Texas Capital Bank Wealth Management Services first reported a position in NVS in Q3 2020 and has held it in 2 quarters since. The position peaked at $2.25M in Q3 2020. 1,592 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Texas Capital Bank Wealth Management Services held 2,205 shares of Novartis worth $337K as of Q1 2026.
  • Novartis was a new Texas Capital Bank Wealth Management Services position in Q1 2026.
  • Novartis made up 0.02% of Texas Capital Bank Wealth Management Services's portfolio in Q1 2026, its #255 holding.
  • Texas Capital Bank Wealth Management Services first reported a position in Novartis in Q3 2020 and has held it in 2 quarters since.
  • Texas Capital Bank Wealth Management Services's Novartis position peaked at $2.25M in Q3 2020.
  • 1,592 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Texas Capital Bank Wealth Management Services's 13F filing for Q1 2026, filed 11 May 2026.